azathioprine has been researched along with Diabetic Neuropathies in 6 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Azathioprine was started." | 1.42 | CIDP variants in diabetes: measuring treatment response with a small nerve fiber test. ( Névoret, ML; Vinik, AI, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Névoret, ML | 1 |
| Vinik, AI | 1 |
| Haq, RU | 1 |
| Pendlebury, WW | 1 |
| Fries, TJ | 1 |
| Tandan, R | 1 |
| Pedersen, K | 1 |
| Pandolfo, M | 1 |
| Mavroudakis, N | 1 |
| Krendel, DA | 1 |
| Costigan, DA | 1 |
| Hopkins, LC | 1 |
| Stratta, RJ | 1 |
| D'Alessandro, AM | 1 |
| Armbrust, MJ | 1 |
| Pirsch, JD | 1 |
| Sollinger, HW | 1 |
| Kalayoglu, M | 1 |
| Belzer, FO | 1 |
| Goetz, FC | 1 |
| Elick, B | 1 |
| Fryd, D | 1 |
| Sutherland, DE | 1 |
1 review available for azathioprine and Diabetic Neuropathies
| Article | Year |
|---|---|
Renal transplantation in diabetes.
Topics: Adolescent; Adult; Age Factors; Azathioprine; Child; Costs and Cost Analysis; Diabetes Mellitus; Dia | 1986 |
1 trial available for azathioprine and Diabetic Neuropathies
| Article | Year |
|---|---|
Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Clinical Trials as Topic; Cyclosporins; Diabetic Neuropat | 1989 |
4 other studies available for azathioprine and Diabetic Neuropathies
| Article | Year |
|---|---|
CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
Topics: Autonomic Nervous System; Azathioprine; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diabet | 2015 |
Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.
Topics: Adjuvants, Immunologic; Adult; Azathioprine; Diabetic Neuropathies; Female; Humans; Immunoglobulins, | 2003 |
Chronic inflammatory demyelinating polyneuropathy in a diabetic patient: deterioration after intravenous immunoglobulins treatment and favorable response to steroid treatment.
Topics: Azathioprine; Diabetic Neuropathies; Disease Progression; Female; Humans; Immunoglobulins, Intraveno | 2007 |
Successful treatment of neuropathies in patients with diabetes mellitus.
Topics: Aged; Azathioprine; Cyclophosphamide; Demyelinating Diseases; Diabetes Mellitus, Type 1; Diabetes Me | 1995 |